Chapter 6 Glutamate receptors and the induction of excitotoxic neuronal death
References (20)
- et al.
Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
Trends Neurosci.
(1993) Glutamate neurotoxicity and diseases of the nervous system
Neuron
(1988)- et al.
Determinants of Ca++ permeability in both TM1 and TM2 of high affinity kainate receptor channels: diversity by RNA editing
Neuron
(1993) - et al.
The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury
Eur. J. Pharmacol
(1992) - et al.
Agonist-activated cobalt uptake identifies divalent cationpermeable kainate receptors on neurons and glial cells
Neuron.
(1991) - et al.
Metabotropic glutamate receptors in brain function and pathology
Trends Pharmacol. Sci.
(1993) - et al.
Glutamate receptor channels: novel properties and new clones
Trends Pharmacol. Sci.
(1992) - et al.
Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists
Trends Pharmacol. Sci.
(1990) - et al.
Cyclothiazide potentiates AMPA neurotoxicity and oxygen-glucose deprivation injury in cortical culture
Soc. Neurosci. Abstr.
(1993) Excitotoxic cell death
J. Neurobiol.
(1992)
There are more references available in the full text version of this article.
Cited by (373)
Behavioural effects in mice orally exposed to domoic acid or ibotenic acid are influenced by developmental stages and sex differences
2021, Biochemical and Biophysical Research CommunicationsEpigenetics in child psychiatry
2021, Epigenetics in PsychiatryCommunication of Glioma cells with neuronal plasticity: What is the underlying mechanism?
2020, Neurochemistry InternationalCitation Excerpt :Glutamate is the predominant excitatory neurotransmitter in the human brain playing a vital role in neuroplasticity, neurogenesis, synaptic strength, memory and cognition (Mattson 2008; Shepherd and Huganir 2007). Nonetheless, the prolonged activation of glutamate receptors also leads to neurotoxicity, neuropsychiatric disorders, cerebral edema and the emergence of gliomas (Choi 1988, 1994; Werth et al., 1998; Doble 1999; Sheldon and Robinson 2007). The neurotransmitter release has also been linked to glioma-induced epilepsy, which is a dominant side effect of this tumor condition (Buckingham et al., 2011).
2.24 - Physiology and Pharmacology of the Cochlea
2020, The Senses: A Comprehensive Reference: Volume 1-7, Second Edition
Copyright © 1994 Elsevier Science Publishers, B.V. Published by Elsevier B.V. All rights reserved.